The Cytel Blog: Perspectives on Enquiry & Evidence

When Cyrus Mehta introduced the Promising Zone Design over a decade ago, the new statistical method not only..

Much of the discussion about clinical trial design considers methods to optimize performance characteristics and..

Next week’s PSI Conference will feature Dr. Yannis Jemiai speaking on the use of Scoring Functions in the re-imagined..

When developing clinical strategy, applying familiar business principles to the specific requirements of clinical..

Recently, Cytel co-founder Professor Cyrus Mehta noted that, “Clinical trial design selection is too much like an art,..

For much of the past three decades, even as methodologies for clinical trial design have advanced and refined, the idea..

The use of wearable and digital technology requires considerations for both drugs and devices regulations, and..

Over the past ten years High-Performance Computing (HPC) has transformed medical research through advances in genomics,..

With wearables likely to become a regular part of clinical trial design, statisticians could benefit by familiarizing..